BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2197239)

  • 21. Tumor markers in inclusion cysts of the ovary.
    Blaustein A; Kaganowicz A; Wells J
    Cancer; 1982 Feb; 49(4):722-6. PubMed ID: 7034921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of biochemical markers between benign and malignant ovarian cysts.
    Knight JA; Wu JT; Miya T; Knight DP
    Clin Physiol Biochem; 1986; 4(2):130-5. PubMed ID: 3516514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors.
    Vitiazeva V; Kattla JJ; Flowers SA; Lindén SK; Premaratne P; Weijdegård B; Sundfeldt K; Karlsson NG
    PLoS One; 2015; 10(6):e0130197. PubMed ID: 26075384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoembryonic antigen in primary and metastatic ovarian tumors.
    Fleuren GJ; Nap M
    Gynecol Oncol; 1988 Jul; 30(3):407-15. PubMed ID: 2839395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of epidermal growth factor-related proteins and epidermal growth factor receptor in common epithelial ovarian tumors.
    Niikura H; Sasano H; Sato S; Yajima A
    Int J Gynecol Pathol; 1997 Jan; 16(1):60-8. PubMed ID: 8986534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ferritin levels of ascites and the contents of cystic ovarian tumors--possibilities of ferritin production and secretion by malignant tumor cells].
    Okamoto M; Fukasawa H; Hirata F; Hoshi S
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):240-6. PubMed ID: 6696460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinations.
    van Nagell JR; Donaldson ES; Gay EC; Sharkey RM; Rayburn P; Goldenberg DM
    Cancer; 1978 Jun; 41(6):2335-40. PubMed ID: 350376
    [No Abstract]   [Full Text] [Related]  

  • 29. Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA.
    Neunteufel W; Breitenecker G
    Gynecol Oncol; 1989 Mar; 32(3):297-302. PubMed ID: 2646183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucinous tumors of the ovary with argyrophil cells. An immunohistochemical analysis.
    Aguirre P; Scully RE; Dayal Y; DeLellis RA
    Am J Surg Pathol; 1984 May; 8(5):345-56. PubMed ID: 6203413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunohistochemical localization of estradiol in malignant epithelial tumors of the ovary].
    Takamizawa M; Yaoi Y; Kumasaka T; Saito M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):359-66. PubMed ID: 3559322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of carcinoembryonic antigen and periodic acid-Schiff stains in the diagnosis of serous and mucinous ovarian tumors: morphometrical study.
    Aalto ML; Selkäinaho K; Collan Y
    Appl Pathol; 1986; 4(1-2):83-9. PubMed ID: 3034311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucoid carcinomas of the breast: a study using mucin histochemistry and peanut lectin.
    Walker RA
    Histopathology; 1982 Sep; 6(5):571-9. PubMed ID: 6183186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of immunohistochemical staining panel for characterisation of ovarian neoplasms.
    Ashorn P; Helle M; Helin H; Ashorn R; Krohn K
    J Clin Pathol; 1988 Jan; 41(1):12-6. PubMed ID: 2449464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood group substance, CEA, and lectins in ovarian tumors.
    Dietel M; Arps H; Hölzel F; Viale G; Dell'Orto P; Kröger A; Niendorf A
    Cancer Detect Prev; 1986; 9(5-6):511-20. PubMed ID: 3465441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
    Ramalingam P
    Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p63 expression in epithelial ovarian tumors.
    Poli Neto OB; Candido Dos Reis FJ; Zambelli Ramalho LN; Nogueira AA; de Andrade JM
    Int J Gynecol Cancer; 2006; 16(1):152-5. PubMed ID: 16445626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience.
    Linder JD; Geenen JE; Catalano MF
    Gastrointest Endosc; 2006 Nov; 64(5):697-702. PubMed ID: 17055859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S-100 protein in ovarian tumors. A comparative immunohistochemical study of 135 cases.
    Lin M; Hanai J; Wada A; Ozaki M; Nasu K; Okamoto S; Matsumoto K
    Acta Pathol Jpn; 1991 Mar; 41(3):233-9. PubMed ID: 2068948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.